NOVADEL PHARMA INC·4

Aug 1, 7:43 PM ET

KESSEL LARRY 4

4 · NOVADEL PHARMA INC · Filed Aug 1, 2005

Insider Transaction Report

Form 4
Period: 2005-07-28
KESSEL LARRY
Director
Transactions
  • Disposition to Issuer

    Stock Option (right to buy)

    2005-07-2850,0000 total
    Exercise: $1.41Exp: 2010-02-27Common Stock (50,000 underlying)
  • Award

    Stock Option (right to buy)

    2005-07-28+50,00050,000 total
    Exercise: $1.41Exp: 2010-02-27Common Stock (50,000 underlying)
Footnotes (2)
  • [F1]16,666 options become exercisable on February 27, 2006, 16,667 options become exercisable on February 27, 2007, and 16,667 options becomes exercisable on February 27, 2008.
  • [F2]On July 28, 2005, the issuer canceled, pursuant to a disclosure and release agreement, a five-year option granted to the reporting person on February 28, 2005 for 50,000 shares at $1.41 per share. In exchange, the reporting person received options for 50,000 shares at $1.41 as described herein.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT